Amiodarone causes acute oxidant lung injury in ventilated and perfused rabbit lungs

Thomas P. Kennedy, Gary B. Gordon, Andreas Paky, Alan McShane, N. Franklin Adkinson, Stephen P. Peters, Karen Friday, Warren Jackman, A. Mario Sciuto, Gail H. Gurtner

Research output: Contribution to journalArticlepeer-review

Abstract

Amiodarone (ADR), a new antiarrhythmic drug for life-threatening cardiac arrhythmias, causes pneumonitis or lung fibrosis in a sizeable minority of patients. The cause of lung damage is not known. We have shown that infusion of 10 mg amiodarone into the inflow circuit of ventilated and perfused rabbit lungs causes immediate increase in pulmonary artery pressure (mean ± SEM) (from 13.6 ± 1.2 to 40.6 ± 9.5 mm Hg, p < 0.01) and pulmonary edema with marked increase in the pulmonary generation of thromboxane and leukotrienes C4 and/or D4. Albumin (2 g%) in the perfusate prevents any increase in lung perfusion pressure or edema formation. When lung perfusion pressure increase is blocked with the combined cyclooxygenase and lipoxygenase inhibitor enolicam sodium (CG5391B, 35 μM in perfusate), significant lung edema still occurs after amiodarone, indicating that amiodarone causes increased alveolar-capillary membrane permeability. Addition of catalase (100 U/ml) or superoxide dismutase and catalase (100 U/ml each) to perfusate fails to protect from amiodarone lung injury. Immediate infusion of amiodarone (10 mg) into lungs ventilated with room air (ADR + RA) causes an increase in lung weight gain from baseline (ΔW) of 5.7 ± 1.5 g/min. Compared with ADR + RA, ventilation of lungs with 4% O2 (ΔW = 0.7 ± 0.3 g/min, p < 0.05). pretreatment of rabbits for 3 days with butylated hydroxyanisole (BHA, 100 mg/kg/day i.p., ΔW = 0.05 ± 0.02 g/min, p < 0.01), pretreatment of rabbits for 3 days with vitamin E (Vit E, 300 U/day orally, ΔW = 0.6 ± 0.2 g/min, p < 0.05), or addition of N-acetylcysteine to the lung perfusate (NAC, 5 mM, ΔW = 0.1 ± 0.08 g/min, p < 0.01) all protect from lung edema formation after amiodarone. Amiodarone (100 mg) also caused a marked increase in luminol-enhanced lung chemiluminescence, lung production of superoxide anion (O2 ), and tissue levels of lung glutathione disulfide. These results suggest that amiodarone causes lung injury by an oxidant mechanism.

Original languageEnglish (US)
Pages (from-to)23-36
Number of pages14
JournalJournal of cardiovascular pharmacology
Volume12
Issue number1
DOIs
StatePublished - Jul 1988

Keywords

  • Amiodarone
  • Glutathione disulfide
  • Oxidants
  • Superoxide anion

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Amiodarone causes acute oxidant lung injury in ventilated and perfused rabbit lungs'. Together they form a unique fingerprint.

Cite this